The journal Emerging Microbes & Infections (EMI), launched earlier this month, has gone live at www.nature.com/emi, publishing original research to a broad global audience. The journal is open access and, according to the publisher, original research papers are accompanied by professionally written research summaries, making the findings accessible to a wider audience.
Published in partnership with Nature Publishing Group (NPG), EMI is projected as a fully peer-reviewed international journal covering all areas of emerging microbes and infectious diseases.
The founding Co-Editors-in-Chief are Professors Yumei Wen (Fudan, University, China) and Hans-Dieter Klenk (Marburg Institute of Virology, Germany). They are supported by a team of 90 editorial board members from 18 countries.
EMI publishes reviews, articles and reports on important discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens), including their previously unknown phenotypic or genotypic characteristics. It also reports on the latest information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.
The journal is published biweekly in English as papers are accepted. All articles published in EMI will be open access, on payment of an article processing charge (APC). Authors will have a choice of two Creative Commons (CC) licences.
The research summaries are projected as professionally written, 100-150 word synopses of selected articles that succinctly provide information to the reader about the aims, main outcomes and significant conclusions of the articles. Published under a CC licence, authors and others will be able to re-use, re-post, host and e-mail the research summaries.